Epclusa Fact Sheet
![](local/cache-gd2/02/87b230ced33025ddf5933cf9023ae7.png?1647241588)
Epclusa is a fixed-dose combination of two HCV-fighting drugs (sofosbuvir and velpatasvir) in one pill. In the United States, Epclusa is approved for people with all hepatitis C genotypes (1–6) who are 18 years of age and older. The fact sheet provides information about this treatment regimen.